MARKET

BNR

BNR

Burning Rock Biotech Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.350
-0.110
-3.18%
After Hours: 3.310 -0.04 -1.19% 17:03 08/09 EDT
OPEN
3.390
PREV CLOSE
3.460
HIGH
3.395
LOW
3.260
VOLUME
171.13K
TURNOVER
0
52 WEEK HIGH
23.51
52 WEEK LOW
1.740
MARKET CAP
352.38M
P/E (TTM)
-2.4998
1D
5D
1M
3M
1Y
5Y
Burning Rock Biotech (NASDAQ:BNR) shareholders have endured a 84% loss from investing in the stock a year ago
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
Simply Wall St. · 1d ago
Burning Rock Provides Second Quarter 2022 Business Updates and Schedules Earnings Release on August 31, 2022
GUANGZHOU, China, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today a...
GlobeNewswire · 5d ago
Burning Rock Announces 2022 Annual General Meeting to be Held on September 8, 2022
GUANGZHOU, China, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today ...
GlobeNewswire · 08/03 06:12
Burning Rock Announces Resignation of Director
GUANGZHOU, China, July 14, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today a...
GlobeNewswire · 07/15 01:50
ARWR, TRIP and CARA among after hour movers
Gainers: Burning Rock Biotech (BNR) +4%. TripAdv...
Seekingalpha · 07/08 21:17
What Is The Ownership Structure Like For Burning Rock Biotech Limited (NASDAQ:BNR)?
If you want to know who really controls Burning Rock Biotech Limited ( NASDAQ:BNR ), then you'll have to look at the...
Simply Wall St. · 07/08 10:49
Burning Rock Announces the Launch of China’s First Prospective Interventional Validation Study on Multi-Cancer Early Detection - the PREVENT Study
CHENGDU, China, June 30, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today ann...
GlobeNewswire · 06/30 14:57
NeuroSense, Rapid Micro top healthcare gainers; Renalytix, Angion lead losers' pack
Gainers: NeuroSense Therapeutics (NRSN) +53%. Rapid Micro B...
Seekingalpha · 06/30 14:06
More
No Data
Learn about the latest financial forecast of BNR. Analyze the recent business situations of Burning Rock Biotech Ltd through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

25.00%Strong Buy
75.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BNR stock price target is 11.23 with a high estimate of 14.18 and a low estimate of 6.70.
High14.18
Average11.23
Low6.70
Current 3.350
EPS
Actual
Estimate
-0.31-0.23-0.16-0.08
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 60
Institutional Holdings: 29.32M
% Owned: 27.87%
Shares Outstanding: 105.19M
TypeInstitutionsShares
Increased
16
5.85M
New
2
49.30K
Decreased
20
1.27M
Sold Out
18
2.05M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.36%
Healthcare Providers & Services
+0.27%
Key Executives
Chairman/Chief Executive Officer/Founder/Director
Yansheng Han
Chief Financial Officer/Director
Leo Li
Chief Operating Officer/Director
Shaokun Chuai
Chief Technology Officer
Zhihong Zhang
Director
Feng Deng
Director
Gang Lu
Director
Jing Rong
Director
Yunxia Yang
Independent Director
Wendy Hayes
Independent Director
Min-jui Shen
No Data
No Data
About BNR
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Webull offers kinds of Burning Rock Biotech Ltd(ADR) stock information, including NASDAQ:BNR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNR stock methods without spending real money on the virtual paper trading platform.